Probiotics Against Pathogenic Bacteria in Connection With Anaesthesia
Probiotics for Reduction of Colonisation With Pathogenic Bacteria in the Oropharynx in Connection With Anaesthesia
1 other identifier
interventional
42
1 country
1
Brief Summary
Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx. Healthy people seldom have pathogenic bacteria originating from the gastro-intestinal canal but those do occur among patients, both in those not so sick and patients with more severe problems. For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral care with probiotics and this is a pilot study to explore the possibility of the same kind of positive effects in patients due for longer (more than 4 hours of anesthesia) procedures. Randomisation
- No prophylaxis
- Preparation with a probiotic suspension before intubation. Cultures
- oropharynx
- before treatment
- after intubation
- before extubation
- day 1 postoperatively
- tracheal secretions
- after intubation
- before extubation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 26, 2012
CompletedFirst Posted
Study publicly available on registry
January 31, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedMarch 10, 2021
March 1, 2021
7.2 years
January 26, 2012
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences in pathogenic bacteria in the oropharynx and lower airways
Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in conection with anaestesia and a surgical intervention
During hospitalization, up to 4 weeks
Secondary Outcomes (4)
White blood cells
During hospitalization, up to 4 weeks
CRP
During hospitalization, up to 4 weeks
Pneumonia
Up till 7 days postoperatively
Length of hospital stay
time to discharged from hospital or patients death
Study Arms (2)
Probiotics
EXPERIMENTALPatients will gurgle and swallow a mixture of probiotic bacteria
Control
NO INTERVENTIONNo intervention. What has been the standard procedure so far
Interventions
Patients will gurgle and swallow a mixture of probiotic bacteria
Eligibility Criteria
You may qualify if:
- Adult patients
- Planned interventions
- Anaesthesia \> 4 hours and requiring intubation
You may not qualify if:
- Ulcers in the mouth, oropharynx, oesophagus and stomach
- Current infections in the airways
- Known immuno deficiences
- Emergency cases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
- Lund Universitycollaborator
Study Sites (1)
Lund University Hospital
Lund, SE-22185, Sweden
Related Publications (2)
Stjernquist-Desatnik A, Warfving H, Johansson ML. Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. A pilot study. Acta Otolaryngol Suppl. 2000;543:215-9. doi: 10.1080/000164800454422.
PMID: 10909023BACKGROUNDKlarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136. doi: 10.1186/cc7109. Epub 2008 Nov 6.
PMID: 18990201BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bengt klarin, MD PhD
Lund University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Consultant
Study Record Dates
First Submitted
January 26, 2012
First Posted
January 31, 2012
Study Start
January 1, 2012
Primary Completion
March 1, 2019
Study Completion
July 1, 2020
Last Updated
March 10, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will share
Results are intended to be published in a scientific journal